Benjamin L. Palleiko
2017
In 2017, Benjamin L. Palleiko earned a total compensation of $923.9K as Chief Business Officer and Chief Financial Officer at Carbylan Therapeutics.
Compensation breakdown
| Bonus | $95,000 |
|---|---|
| Option Awards | $589,390 |
| Salary | $239,492 |
| Total | $923,882 |
Palleiko received $589.4K in option awards, accounting for 64% of the total pay in 2017.
Palleiko also received $95K in bonus and $239.5K in salary.
Rankings
In 2017, Benjamin L. Palleiko's compensation ranked 9,338th out of 14,666 executives tracked by ExecPay. In other words, Palleiko earned more than 36.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,338 out of 14,666 | 36th |
Division Manufacturing | 3,585 out of 5,768 | 38th |
Major group Chemicals And Allied Products | 1,233 out of 2,074 | 41st |
Industry group Drugs | 992 out of 1,730 | 43rd |
Industry Pharmaceutical Preparations | 779 out of 1,329 | 41st |
Source: SEC filing on August 23, 2019.
Palleiko's colleagues
We found one more compensation record of an executive who worked with Benjamin L. Palleiko at Carbylan Therapeutics in 2017.
2017
T Crockett
Carbylan Therapeutics